View in EDS HTML Full Text PDF Full Text

Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab.

Saved in:
Bibliographic Details
Title: Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab.
Authors: Chen IW; Division of Endocrinology and Metabolism, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City, Taiwan., Lin CW; Division of Endocrinology and Metabolism, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; School of Medicine, National Tsing Hua University, Hsinchu City, Taiwan., Lin PT; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Teng W; College of Medicine, Chang Gung University, Taoyuan City, Taiwan. b101090023@gmail.com.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan. b101090023@gmail.com.; Liver Research Center, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan. b101090023@gmail.com., Su CW; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Wu TH; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of General Surgery, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Hsieh YC; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Chen WT; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Lin CC; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, New Taipei Municipal Tucheng Hospital (Built and Operated By Chang Gung Memorial Hospital), New Taipei City, Taiwan., Lin SM; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Lin CY; College of Medicine, Chang Gung University, Taoyuan City, Taiwan. chunyenlin@gmail.com.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan. chunyenlin@gmail.com.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Jan 27; Vol. 75 (2), pp. 59. Date of Electronic Publication: 2026 Jan 27.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41591568
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chen+IW%22">Chen IW</searchLink>; Division of Endocrinology and Metabolism, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+CW%22">Lin CW</searchLink>; Division of Endocrinology and Metabolism, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; School of Medicine, National Tsing Hua University, Hsinchu City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+PT%22">Lin PT</searchLink>; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Teng+W%22">Teng W</searchLink>; College of Medicine, Chang Gung University, Taoyuan City, Taiwan. b101090023@gmail.com.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan. b101090023@gmail.com.; Liver Research Center, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan. b101090023@gmail.com.<br /><searchLink fieldCode="AU" term="%22Su+CW%22">Su CW</searchLink>; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Wu+TH%22">Wu TH</searchLink>; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of General Surgery, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hsieh+YC%22">Hsieh YC</searchLink>; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+WT%22">Chen WT</searchLink>; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+CC%22">Lin CC</searchLink>; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, New Taipei Municipal Tucheng Hospital (Built and Operated By Chang Gung Memorial Hospital), New Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+SM%22">Lin SM</searchLink>; College of Medicine, Chang Gung University, Taoyuan City, Taiwan.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+CY%22">Lin CY</searchLink>; College of Medicine, Chang Gung University, Taoyuan City, Taiwan. chunyenlin@gmail.com.; Department of Gastroenterology and Hepatology, Linkou Medical Center, Chang Gung Memorial Hospital, Taoyuan City, Taiwan. chunyenlin@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2026 Jan 27; Vol. 75 (2), pp. 59. <i>Date of Electronic Publication: </i>2026 Jan 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41591568
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-026-04308-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 59
    Titles:
      – TitleFull: Non-thyroidal illness syndrome predicts poor prognosis in hepatocellular carcinoma patients treated with atezolizumab and bevacizumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen IW
      – PersonEntity:
          Name:
            NameFull: Lin CW
      – PersonEntity:
          Name:
            NameFull: Lin PT
      – PersonEntity:
          Name:
            NameFull: Teng W
      – PersonEntity:
          Name:
            NameFull: Su CW
      – PersonEntity:
          Name:
            NameFull: Wu TH
      – PersonEntity:
          Name:
            NameFull: Hsieh YC
      – PersonEntity:
          Name:
            NameFull: Chen WT
      – PersonEntity:
          Name:
            NameFull: Lin CC
      – PersonEntity:
          Name:
            NameFull: Lin SM
      – PersonEntity:
          Name:
            NameFull: Lin CY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 01
              Text: 2026 Jan 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Numbering:
            – Type: volume
              Value: 75
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1